1. Docarmo AM, Cunha-Filho MSS, Gelfuso GM, Gratieri T (2017) Evolution of quality on pharmaceutical design: regulatory requirement? Accred Qual Assur 22:199–205
2. Woodcock J, Woosley R (2008) The FDA critical path initiative and its influence on new drug development. Annu Rev Med 59:1–12
3. FDA (2020) Quality systems approach to pharmaceutical cGMP regulations
4. BEG S, Hasnain MS (2019) Pharmaceutical quality by design: principles and applications. Academic Press, Cambridge, MA
5. Chobisa D (2019) QbD-based development of pharmaceutical parenteral drug products: an overview. In: Pharmaceutical quality by design. Elsevier, Amsterdam